Skip to content
PEGS Boston 2015 | Analytical Technologies for Characterizing Circulating ADC Species episode artwork

Feb 20, 2015 12 min

PEGS Boston 2015 | Analytical Technologies for Characterizing Circulating ADC Species

from CHI Podcasts Hosted by Cambridge Healthtech Podcasts

This podcast presents an interview with Dr. John Kellie, an Investigator in the Bioanalytical Sciences and Toxicokinetics group at GlaxoSmithKline, and a speaker in the Characterization of Biotherapeutics meeting at the 11th Annual PEGS Boston. John explains how next-generation analytical technologies are being used to characterize circulating ADC species, and how these findings support the development of safe and effective antibody-drug conjugate therapeutics. To learn more, visit http://www.PEGSummit.com/Biotherapeutics-Characterization

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

PEGS Boston 2015 | Analytical Technologies for Characterizing Circulating ADC Species

0:00 12:43

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of CHI Podcasts?

This episode is 12 minutes long.

When was this CHI Podcasts episode published?

This episode was published on February 20, 2015.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.